Bonni Goldstein
Chief Medical Advisor, USA / Neurotech International
| Rank | Company | # | |
|---|---|---|---|
| 115th | - | Neurotech International | $2.44m |
| 125th | - | 333D | $1.51m |
| 126th | - | Peppermint Innovation | $1.37m |
| 127th | - | Zelira Therapeutics | $1.16m |
| 128th | - | ClearVue Technologies | $1.11m |
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 1587th | Serko | -60.44% | -26.09% |
| 1588th | Avita Medical | -60.46% | -26.67% |
| 1589th | Neurotech International | -60.59% | -29.76% |
| 1590th | Austin Engineering | -60.76% | 4.17% |
| 1591st | HMC Capital | -60.88% | -9.72% |
|
NEW ROLE: Chief Medical Advisor, USA, Neurotech International | 25 Jun 2025 |
Access to our data for Bonni Goldstein is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Bonni Goldstein is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.